Uncomplicating Diabetes: Reducing the Burden of Diabetes Related End-Organ Injury
Santa Fe, New Mexico
This Keystone Symposia conference will address diabetic complications which
remain the major cause of morbidity and mortality in the diabetic population.
Although the outlook has improved over the last two decades with respect to
diabetic vascular disease, these complications remain a major burden with the
underlying explanation for these complications at a molecular and cellular level
as yet not fully clarified. With recent advances in the management of diabetes,
particularly new classes of glucose-lowering agents, it is critical to determine
if these new therapies have both glucose-dependent and independent effects in
reducing diabetes-related end-organ injury. With major advances in our
understanding of key pathological features of diabetic complications such as
angiogenesis, fibrosis, inflammation and vascular remodeling, albeit in
non-diabetic contexts, now is the time to translate this new knowledge to the
field of diabetic complications. By learning from and recruiting such
researchers into the field of diabetic complications, there is a great
opportunity to develop novel, highly innovative approaches to identify new
targets in order to discover new ways to treat, reverse or prevent diabetic
complications that lead to premature atherosclerosis, heart failure, blindness,
cognitive impairment and end-stage renal disease.
No meeting documents found.
Safari Browser Detected...
I see you are using a
to navigate our site.
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers: